Agilent Acquire SLIMS Owner Genohm
Agilent Technologies, Inc. today announced that it has entered into a definitive agreement to acquire privately-held Genohm, a developer of highly differentiated, on-premise and cloud-based software solutions for laboratory management.
Genohm's main laboratory software automation suite, SLIMS, is a digital platform that provides laboratories with a rapidly deployable and seamless laboratory information management system (LIMS) and electronic lab notebook (ELN) environment that is used in biobanks, research labs and next gen sequencing facilities. The platform tracks data and samples, tests and users, results and workflows, from the original material shipment to the result from lab instruments and in-silico analysis pipelines. Genohm also has an application marketplace with preconfigured workflows to enable rapid system implementation across a broad range of industries and scientific workflows.
Customers are looking to generate better answers, and this requires integrated informatics solutions. This acquisition enhances Agilent's current software portfolio, adding LIMS and workflow management, while expanding ELN capability. This combination will allow Agilent to bring greater context to analytical data, enabling scientists to generate results more efficiently.
"We were impressed with the team and the technology," said John Sadler, Vice President and General Manager of Agilent's Software and Informatics Division. "The modern architecture of SLIMS is perfectly aligned with the values of Agilent's OpenLab products. By integrating this technology with our broad and diverse instrument portfolio, we are in a unique position to support and enhance the operations of modern laboratories—truly helping our customers to do more with their data."
"Genohm has an excellent footprint in the genomics space," said Kamni Vijay, Ph.D., Vice President and General Manager of Agilent's Genomics Division. "This acquisition supports our strategy to offer complete next-generation sequencing workflows and improve the laboratory management of our genomic customers."
"We are very excited to join the Agilent team and believe that together we can accelerate development of the digital lab to help our customers advance science and discovery while ensuring compliance and traceability," said Frederik Decouttere, founder and CEO of Genohm. "Our laboratory management platform is highly configurable, easily deployable and leverageable across many different workflows, which makes our technology a perfect fit for Agilent."
Linguamatics iScite 2.0 Wins Bio-IT World’s Best of Show Judges’ PrizeNews
Linguamatics today announced that Bio-IT World has awarded Linguamatics the Best of Show Judges’ Prize for Linguamatics iScite 2.0, a software-as-a-service AI scientific search application. iScite was one of 46 products considered for this prestigious award at last week’s Bio-IT World Conference & Expo in Boston.
Understanding Lung Cancer Cell Networks Helps Create Drug TreatmentsNews
A team of scientists has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.READ MORE